BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Death of the 20-minute Rule
News | 11. 01. 2009
Venture capitalists have always preferred their backyards. This preference is captured in the so-called "20-minute rule," which describes an investor's tendency to invest in companies located within a 20-minute drive of the fund's office.
